Concepedia

William J. Sandborn

WJ

Statistics

Publications

713

Citations

120.7K

H-Index

170

Active since

1991

Affiliations

University of California San Diego(Current)

Mayo Clinic

Western University

Icahn School of Medicine at Mount Sinai

Mayo Clinic in Arizona

William J. Sandborn is an author at University of California San Diego specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and gastrointestinal inflammation.

ORCID

Publications per year

1991–2025

713

Publications

713

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +14

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

, , +14

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn, Brian G. Feagan, Paul Rutgeerts et al. · New England Journal of Medicine · 2013 · 2.7K citations · Full text

, , +14

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

Jean–Frédéric Colombel, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 2.3K citations · Full text

, , +16

1–5 of 713